Literature DB >> 17644531

Crystal structures of high affinity human T-cell receptors bound to peptide major histocompatibility complex reveal native diagonal binding geometry.

Malkit Sami1, Pierre J Rizkallah, Steve Dunn, Peter Molloy, Ruth Moysey, Annelise Vuidepot, Emma Baston, Penio Todorov, Yi Li, Feng Gao, Jonathan M Boulter, Bent K Jakobsen.   

Abstract

Naturally selected T-cell receptors (TCRs) are characterised by low binding affinities, typically in the range 1-100 microM. Crystal structures of syngeneic TCRs bound to peptide major histocompatibility complex (pMHC) antigens exhibit a conserved mode of binding characterised by a distinct diagonal binding geometry, with poor shape complementarity (SC) between receptor and ligand. Here, we report the structures of three in vitro affinity enhanced TCRs that recognise the pMHC tumour epitope NY-ESO(157-165) (SLLMWITQC). These crystal structures reveal that the docking mode for the high affinity TCRs is identical to that reported for the parental wild-type TCR, with only subtle changes in the mutated complementarity determining regions (CDRs) that form contacts with pMHC; both CDR2 and CDR3 mutations act synergistically to improve the overall affinity. Comparison of free and bound TCR structures for both wild-type and a CDR3 mutant reveal an induced fit mechanism arising from restructuring of CDR3 loops which allows better peptide binding. Overall, an increased interface area, improved SC and additional H-bonding interactions are observed, accounting for the increase in affinity. Most notably, there is a marked increase in the SC for the central methionine and tryptophan peptide motif over the native TCR.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17644531     DOI: 10.1093/protein/gzm033

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  36 in total

1.  Identification and engineering of human variable regions that allow expression of stable single-chain T cell receptors.

Authors:  David H Aggen; Adam S Chervin; Francis K Insaidoo; Kurt H Piepenbrink; Brian M Baker; David M Kranz
Journal:  Protein Eng Des Sel       Date:  2010-12-14       Impact factor: 1.650

2.  Crystallization and preliminary X-ray crystallographic characterization of a public CMV-specific TCR in complex with its cognate antigen.

Authors:  Jean Baptiste Reiser; François Legoux; Paul Machillot; Emilie Debeaupuis; Béatrice Le Moullac-Vaydie; Anne Chouquet; Xavier Saulquin; Marc Bonneville; Dominique Housset
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-10-30

3.  Distinct sets of alphabeta TCRs confer similar recognition of tumor antigen NY-ESO-1157-165 by interacting with its central Met/Trp residues.

Authors:  Laurent Derré; Marc Bruyninx; Petra Baumgaertner; Mathias Ferber; Daphné Schmid; Antoine Leimgruber; Vincent Zoete; Pedro Romero; Olivier Michielin; Daniel E Speiser; Nathalie Rufer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-22       Impact factor: 11.205

4.  Structures of the antibody 64M-5 Fab and its complex with dT(6-4)T indicate induced-fit and high-affinity mechanisms.

Authors:  Hideshi Yokoyama; Ryuta Mizutani; Shuji Noguchi; Naoki Hayashida
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2019-01-23       Impact factor: 1.056

5.  Combinations of affinity-enhancing mutations in a T cell receptor reveal highly nonadditive effects within and between complementarity determining regions and chains.

Authors:  Brian G Pierce; Jaafar N Haidar; Yong Yu; Zhiping Weng
Journal:  Biochemistry       Date:  2010-08-24       Impact factor: 3.162

6.  Specificity of bispecific T cell receptors and antibodies targeting peptide-HLA.

Authors:  Christopher J Holland; Rory M Crean; Johanne M Pentier; Ben de Wet; Angharad Lloyd; Velupillai Srikannathasan; Nikolai Lissin; Katy A Lloyd; Thomas H Blicher; Paul J Conroy; Miriam Hock; Robert J Pengelly; Thomas E Spinner; Brian Cameron; Elizabeth A Potter; Anitha Jeyanthan; Peter E Molloy; Malkit Sami; Milos Aleksic; Nathaniel Liddy; Ross A Robinson; Stephen Harper; Marco Lepore; Chris R Pudney; Marc W van der Kamp; Pierre J Rizkallah; Bent K Jakobsen; Annelise Vuidepot; David K Cole
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

7.  TCRs with Distinct Specificity Profiles Use Different Binding Modes to Engage an Identical Peptide-HLA Complex.

Authors:  Charlotte H Coles; Rachel M Mulvaney; Sunir Malla; Andrew Walker; Kathrine J Smith; Angharad Lloyd; Kate L Lowe; Michelle L McCully; Ruth Martinez Hague; Milos Aleksic; Jane Harper; Samantha J Paston; Zoe Donnellan; Fiona Chester; Katrin Wiederhold; Ross A Robinson; Andrew Knox; Andrea R Stacey; Joseph Dukes; Emma Baston; Sue Griffin; Bent K Jakobsen; Annelise Vuidepot; Stephen Harper
Journal:  J Immunol       Date:  2020-02-26       Impact factor: 5.422

Review 8.  The molecular basis of TCR germline bias for MHC is surprisingly simple.

Authors:  K Christopher Garcia; Jarrett J Adams; Dan Feng; Lauren K Ely
Journal:  Nat Immunol       Date:  2009-02       Impact factor: 25.606

9.  Structure-based design of a T-cell receptor leads to nearly 100-fold improvement in binding affinity for pepMHC.

Authors:  Jaafar N Haidar; Brian Pierce; Yong Yu; Weiwei Tong; Michael Li; Zhiping Weng
Journal:  Proteins       Date:  2009-03

10.  Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions.

Authors:  Paul F Robbins; Yong F Li; Mona El-Gamil; Yangbing Zhao; Jennifer A Wargo; Zhili Zheng; Hui Xu; Richard A Morgan; Steven A Feldman; Laura A Johnson; Alan D Bennett; Steven M Dunn; Tara M Mahon; Bent K Jakobsen; Steven A Rosenberg
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.